The efficacy of transdermal sumatriptan is too low for general use - a response

Headache. 2014 Jan;54(1):172-4. doi: 10.1111/head.12268.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Dose-Response Relationship, Drug
  • Humans
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / metabolism
  • Sumatriptan / administration & dosage*
  • Sumatriptan / pharmacokinetics
  • Time Factors
  • Treatment Outcome

Substances

  • Sumatriptan